deltatrials
Terminated PHASE3 INTERVENTIONAL 2-arm NCT04743739

Rituximab Combined With Cyclosporine Versus Rituximab Alone in the Treatment of iMN

A Multicenter Randomized Controlled Trial of Rituximab Combined With Cyclosporine Versus Rituximab Alone in the Treatment of Idiopathic Membranous Nephropathy

Sponsor: Beijing Tongren Hospital

Conditions Idiopathic Membranous Nephropathy
Interventions Rituximab cyclosporine
Updated 9 times since 2021 Last updated: Dec 2, 2025 Started: Apr 14, 2021 Primary completion: Dec 20, 2022 Completion: Dec 20, 2024
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

insufficient patient enrollment

Other terminated trials from Beijing Tongren Hospital

See all terminations from Beijing Tongren Hospital

A PHASE3 clinical study on Idiopathic Membranous Nephropathy, this trial is terminated or withdrawn. The trial is conducted by Beijing Tongren Hospital and has accumulated 9 data snapshots since 2021. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

~Mar 2021 – ~Jun 2021 · 3 months · monthly snapshot~Jun 2021 – ~Oct 2021 · 4 months · monthly snapshot~Oct 2021 – ~May 2022 · 7 months · monthly snapshotRecruiting~May 2022 – ~Jul 2024 · 26 months · monthly snapshotRecruiting~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – ~Apr 2025 · 7 months · monthly snapshotRecruiting~Apr 2025 – ~Sep 2025 · 5 months · monthly snapshot~Sep 2025 – ~Jan 2026 · 4 months · monthly snapshot~Jan 2026 – present · 6 months · monthly snapshotTerminated

Change History

9 versions recorded

  1. Jan 2026 — Present [monthly]

    Terminated PHASE3

    Status: Unknown → Terminated

  2. Sep 2025 — Jan 2026 [monthly]

    Unknown PHASE3

  3. Apr 2025 — Sep 2025 [monthly]

    Unknown PHASE3

    Status: Recruiting → Unknown

  4. Sep 2024 — Apr 2025 [monthly]

    Recruiting PHASE3

  5. Jul 2024 — Sep 2024 [monthly]

    Recruiting PHASE3

▶ Show 4 earlier versions

  1. May 2022 — Jul 2024 [monthly]

    Recruiting PHASE3

  2. Oct 2021 — May 2022 [monthly]

    Recruiting PHASE3

  3. Jun 2021 — Oct 2021 [monthly]

    Recruiting PHASE3

  4. Mar 2021 — Jun 2021 [monthly]

    Recruiting PHASE3

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Beijing Tongren Hospital
  • Chinese Academy of Medical Sciences, Fuwai Hospital
  • First Affiliated Hospital of Xinjiang Medical University
  • Peking Union Medical College Hospital
  • Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd.
  • The Luhe Teaching Hospital of the Capital Medical University
  • The Seventh Affiliated Hospital of Sun Yat-sen University
Data source: Peking Union Medical College Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations